Background illustration for clinical trials search

Paid Clinical Trials Bethesda

Discover 2,423 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for
Malignant Female Reproductive System Neoplasm,
Location: Bethesda MD, Fairfax VA, Falls Church VA, Baltimore MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase 2, Recruiting

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

for
Brain Metastases
Location: Bethesda MD, Egg Harbor NJ, Danville PA,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03550391

Phase 3, Recruiting

Hyrax Vs. Invisalign Palatal Expander Clinical Study

for
Malocclusions, Narrow Maxilla, Narrow Maxillary Arch, Crowding
Location: Chevy Chase MD, Warner Robins GA, Naperville IL,
Sponsor: Align Technology, Inc.

Sex: All

Age: 6 - 11

Code: NCT06662279

Recruiting

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for
Crohn's Disease
Location: Chevy Chase MD, Philadelphia PA, New York NY,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase 2, Recruiting

Perception, Sensation, Cognition and Action in Humans

for
Normal Physiology
Location: Bethesda MD
Sponsor: National Eye Institute (NEI)

Sex: All

Age: 13 - 65

Code: NCT03407066

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

for
Inherited Ophthalmic Diseases, Hypopigmentation Disorder,
Location: Bethesda MD
Sponsor: National Eye Institute (NEI)

Sex: All

Age: 0 - 70+

Code: NCT06491615

Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for
Chronic Kidney Disease and Hypertension
Location: Bethesda MD, Washington D.C. DC, Arlington VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06742723

Phase 3, Recruiting

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

for
Advanced Malignant Solid Neoplasm,
Location: Bethesda MD, New York NY, Mineola NY, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05687136

Phase 1, Recruiting

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

for
Advanced Alveolar Soft Part Sarcoma,
Location: Bethesda MD, Washington D.C. DC, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05333458

Phase 2, Recruiting

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

for
Metastatic Malignant Solid Neoplasm,
Location: Bethesda MD, New York NY, Mineola NY, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05687110

Phase 1, Recruiting

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

for
Advanced Malignant Solid Neoplasm,
Location: Bethesda MD, Pittsburgh PA, Trumbull CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05691491

Phase 1, Phase 2, Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

for
Metastatic Dedifferentiated Liposarcoma,
Location: Bethesda MD, Baltimore MD, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05711615

Phase 1, Recruiting

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

for
Focal Onset Seizure, Primary Generalized Epilepsy
Location: Bethesda MD, Hackensack NJ, Middletown NY,
Sponsor: Praxis Precision Medicines

Sex: All

Age: 18 - 70+

Code: NCT06908356

Phase 2, Recruiting

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

for
Coronavirus Infection, Severe Acute Respiratory Infection,
Location: Bethesda MD, Washington DC, Baltimore MD,
Sponsor: Biomed Industries, Inc.

Sex: All

Age: 18 - 70+

Code: NCT04452565

Phase 2, Phase 3, Recruiting

Biospecimen Procurement for Head and Neck Disorders

for
Hearing Disorder, Oral Mucosal Disease, Pharyngeal Neoplasm,
Location: Bethesda MD, Washington D.C. DC, Baltimore MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3 - 70+

Code: NCT03429036

Recruiting

Natural History of Stroke: Cause and Development

for
Brain Disease, Ischemic Attack, Transient,
Location: Bethesda MD, Washington D.C. DC
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 18 - 70+

Code: NCT00009243

Recruiting

Molecular Genetics Studies of Cancer Patients and Their Relatives

for
Malignant Neoplasm
Location: Bethesda MD, Frederick MD, West Reading PA, Paoli PA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 0+

Code: NCT04185935

Recruiting

Proton Radiation Therapy Registry

for
Cancer, Therapy-Related
Location: Washington D.C. DC, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18 - 70+

Code: NCT04376229

Recruiting

Impact of Manual Therapy on Laryngeal Function Following Total Thyroidectomy

for
Total Thyroidectomy
Location: Bethesda MD, Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT06383091

Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for
Biochemically Recurrent Prostate Carcinoma,
Location: Bethesda MD, Washington D.C. DC, Baltimore MD, York PA,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase 3, Recruiting